Found 9971 bookmarks
Newest
Effect of Virtual Reality Simulation Versus Traditional Education on Rates of Clostridium difficile Infection: An Experimental Cluster Randomized Controlled Trial and Return on Investment Analysis - PubMed
Effect of Virtual Reality Simulation Versus Traditional Education on Rates of Clostridium difficile Infection: An Experimental Cluster Randomized Controlled Trial and Return on Investment Analysis - PubMed
Findings showed that VRS was an effective instructional method. [J Contin Educ Nurs. 202x;5x(x):xx-xx.].
·pubmed.ncbi.nlm.nih.gov·
Effect of Virtual Reality Simulation Versus Traditional Education on Rates of Clostridium difficile Infection: An Experimental Cluster Randomized Controlled Trial and Return on Investment Analysis - PubMed
Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group
Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group
Scientific Reports - Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group
·news.google.com·
Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group
Overview of the second edition of the joint British Society of Gastroenterology and Healthcare Infection Society faecal microbiota transplant guidelines, 2024 - PubMed
Overview of the second edition of the joint British Society of Gastroenterology and Healthcare Infection Society faecal microbiota transplant guidelines, 2024 - PubMed
Overview of the second edition of the joint British Society of Gastroenterology and Healthcare Infection Society faecal microbiota transplant guidelines, 2024
·pubmed.ncbi.nlm.nih.gov·
Overview of the second edition of the joint British Society of Gastroenterology and Healthcare Infection Society faecal microbiota transplant guidelines, 2024 - PubMed
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors - PubMed
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors - PubMed
Clostridioides difficile, a gram-positive anaerobic bacterium, is one of the most frequent causes of nosocomial infections. C. difficile infection (CDI) results in almost a half a million infections and approximately 30,000 deaths in the U.S. each year. Broad-spectrum antibacterial use is a strong r …
·pubmed.ncbi.nlm.nih.gov·
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors - PubMed
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors - PubMed
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors - PubMed
Clostridioides difficile, a gram-positive anaerobic bacterium, is one of the most frequent causes of nosocomial infections. C. difficile infection (CDI) results in almost a half a million infections and approximately 30,000 deaths in the U.S. each year. Broad-spectrum antibacterial use is a strong r …
·pubmed.ncbi.nlm.nih.gov·
Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors - PubMed
Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota - PubMed
Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota - PubMed
We developed a novel organoleptically acceptable liquid formulation of fecal microbiota that is suitable for use in clinical trials for patients with difficulties in swallowing capsules.
·pubmed.ncbi.nlm.nih.gov·
Successful Treatment of Recurrent Clostridioides difficile Infection Using a Novel, Drinkable, Oral Formulation of Fecal Microbiota - PubMed
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults - PubMed
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults - PubMed
We confirmed that an alteration in the composition of the core gut microbiota might be biologically relevant to NAFLD development. Our work demonstrated the role of the microbiota in the development of NAFLD.
·pubmed.ncbi.nlm.nih.gov·
Gut microbiome features and metabolites in non-alcoholic fatty liver disease among community-dwelling middle-aged and older adults - PubMed
The Effectiveness of High-dose Intravenous Immunoglobulin for Clostridioides difficile Infection Complicated by Kawasaki Disease: A Pediatric Case Report - PubMed
The Effectiveness of High-dose Intravenous Immunoglobulin for Clostridioides difficile Infection Complicated by Kawasaki Disease: A Pediatric Case Report - PubMed
The Effectiveness of High-dose Intravenous Immunoglobulin for Clostridioides difficile Infection Complicated by Kawasaki Disease: A Pediatric Case Report
·pubmed.ncbi.nlm.nih.gov·
The Effectiveness of High-dose Intravenous Immunoglobulin for Clostridioides difficile Infection Complicated by Kawasaki Disease: A Pediatric Case Report - PubMed
Fungal and bacterial gut microbiota differ between Clostridioides difficile colonization and infection - PubMed
Fungal and bacterial gut microbiota differ between Clostridioides difficile colonization and infection - PubMed
Aim: The bacterial microbiota is well-recognized for its role in Clostridioides difficile colonization and infection, while fungi and yeasts remain understudied. The aim of this study was to analyze the predictive value of the mycobiota and its interactions with the bacterial microbiot …
·pubmed.ncbi.nlm.nih.gov·
Fungal and bacterial gut microbiota differ between Clostridioides difficile colonization and infection - PubMed
On the use of intravenous metronidazole for severe and complicated Clostridioides difficile infection: a review and meta-analysis - PubMed
On the use of intravenous metronidazole for severe and complicated Clostridioides difficile infection: a review and meta-analysis - PubMed
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) has advised against the use of metronidazole for fulminant Clostridioides difficile (C. difficile) infection (CDI) in their latest guidelines. They suggest using oral vancomycin alone instead. This recommenda …
·pubmed.ncbi.nlm.nih.gov·
On the use of intravenous metronidazole for severe and complicated Clostridioides difficile infection: a review and meta-analysis - PubMed
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update - PubMed
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update - PubMed
The bidirectional communication between the gut and brain or gut-brain axis is regulated by several gut microbes and microbial derived metabolites, such as short-chain fatty acids, trimethylamine N-oxide, and lipopolysaccharides. The Gut microbiota (GM) produce neuroactives, specifically neurotransm …
·pubmed.ncbi.nlm.nih.gov·
Protective effects of fecal microbiota transplantation against ischemic stroke and other neurological disorders: an update - PubMed
Effects of fecal microbiota transplantation on metabolic health of DBA mice - PubMed
Effects of fecal microbiota transplantation on metabolic health of DBA mice - PubMed
In summary, FMT from dominant strains improved the growth performance of DBA mice, including body weight gain, institutional growth, and immune performance. This change may be due to the increase of probiotic content in the intestinal tract by FMT and subsequent alteration of intestinal gene express …
·pubmed.ncbi.nlm.nih.gov·
Effects of fecal microbiota transplantation on metabolic health of DBA mice - PubMed
Involvement of gut microbiota in multiple sclerosis-review of a new pathophysiological hypothesis and potential treatment target - PubMed
Involvement of gut microbiota in multiple sclerosis-review of a new pathophysiological hypothesis and potential treatment target - PubMed
Multiple sclerosis (MS) is a chronic inflammatory disease that leads to demyelination and damage to the central nervous system. It is well known, the significance of the involvement and influence of the immune system in the development and course of MS. Nowadays, more and more studies are demonstrat …
·pubmed.ncbi.nlm.nih.gov·
Involvement of gut microbiota in multiple sclerosis-review of a new pathophysiological hypothesis and potential treatment target - PubMed
Recurrence of Clostridioides difficile infection and mortality in older inpatients - PubMed
Recurrence of Clostridioides difficile infection and mortality in older inpatients - PubMed
Clostridioides difficile recurrence is associated with a higher risk of mortality and it may itself be a marker of frailty and vulnerability. Vancomycin treatment during the infectious episode was associated with lower recurrence rate, as compared to metronidazole.
·pubmed.ncbi.nlm.nih.gov·
Recurrence of Clostridioides difficile infection and mortality in older inpatients - PubMed
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection - PubMed
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection - PubMed
SER-109 (VOWST™; fecal microbiota spores, live-brpk) is a live biotherapeutic product indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in patients 18 years of age and older following standard of care (SOC) antibacterial treatment for recurrent CDI. It is a p …
·pubmed.ncbi.nlm.nih.gov·
SER-109 (VOWST™): A Review in the Prevention of Recurrent Clostridioides difficile Infection - PubMed
Clostridium Difficile Infections Market Outlook and Forecast: Analyzing Major Market Trends, Population Segmentation, and Therapeutics Developments in the APAC Region | Acurx, Crestone, MGB Biopharma, Deinove, Biovertis AG, Lumen Bioscience, ImmuniMed
Clostridium Difficile Infections Market Outlook and Forecast: Analyzing Major Market Trends, Population Segmentation, and Therapeutics Developments in the APAC Region | Acurx, Crestone, MGB Biopharma, Deinove, Biovertis AG, Lumen Bioscience, ImmuniMed
DelveInsight s Clostridium Difficile Infections Patient Pool Analysis Market Size and Market Forecast APAC 2034 report provides comprehensive insights into the historical and projected patient burden treatable patient population and notable market trends across the APAC region India China South ...
·news.google.com·
Clostridium Difficile Infections Market Outlook and Forecast: Analyzing Major Market Trends, Population Segmentation, and Therapeutics Developments in the APAC Region | Acurx, Crestone, MGB Biopharma, Deinove, Biovertis AG, Lumen Bioscience, ImmuniMed
Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis - PubMed
Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis - PubMed
Endometriosis (EMs) is a prevalent gynecological disorder characterized by the growth of uterine tissue outside the uterine cavity, causing debilitating symptoms and infertility. Despite its prevalence, the exact mechanisms behind EMs development remain incompletely understood. This article presents …
·pubmed.ncbi.nlm.nih.gov·
Unraveling the microbial puzzle: exploring the intricate role of gut microbiota in endometriosis pathogenesis - PubMed
Atypical Clostridium difficile Infection in a Pregnant Patient: A Case Study on Non-Diarrheal Presentation and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Complication - PubMed
Atypical Clostridium difficile Infection in a Pregnant Patient: A Case Study on Non-Diarrheal Presentation and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Complication - PubMed
Clostridium difficile (C. difficile) is a Gram-positive, spore-producing bacterium that often leads to pseudomembranous colitis, typically manifesting as watery diarrhea. The risk factors for C. difficile infection (CDI) include exposure to broad-spectrum antibiotics, immunocomp …
·pubmed.ncbi.nlm.nih.gov·
Atypical Clostridium difficile Infection in a Pregnant Patient: A Case Study on Non-Diarrheal Presentation and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Complication - PubMed
Prevalence and Antibiotic Resistance of Clostridioides ( Clostridium difficile) In Meat and Meat Products: A Systematic Review and Meta-Analysis - PubMed
Prevalence and Antibiotic Resistance of Clostridioides ( Clostridium difficile) In Meat and Meat Products: A Systematic Review and Meta-Analysis - PubMed
Low resistance was found to commonly used drugs for C. difficile infection (CDI) treatment. Since each antibiotic can be predisposing cause for CDI development, this finding possibly will be warning from a One Health viewpoint about the misuse of antibiotics in the chain of farm to fork inclu …
·pubmed.ncbi.nlm.nih.gov·
Prevalence and Antibiotic Resistance of Clostridioides ( Clostridium difficile) In Meat and Meat Products: A Systematic Review and Meta-Analysis - PubMed
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses - PubMed
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses - PubMed
Immune checkpoint inhibitor (ICI) therapies, such as those blocking the interaction of PD-1 with its ligands, can restore the immune-killing function of T cells. However, ICI therapy is clinically beneficial in only a small number of patients, and it is difficult to predict post-treatment outcomes, …
·pubmed.ncbi.nlm.nih.gov·
Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses - PubMed